iD Rapid® COVID-19 Antigen
Manufactured by Innovative Diagnostics, France - www.innovative-diagnostics.com/
Device identification number
1728
CE Marking
✓Yes
HSC common list (RAT)
×No
Format
Near POC / POC
Physical Support
Lateral flow
Target type
Antigen
Specimen
Nasal swab
Commercial Status
Commercialised
Last Update
2022-08-24 09:08:01 CET
Assay Type
Immuno-Antigen
Rapid Diagnostic
Yes
Reader Required
No
Method
Immunoassay
Measurement
Qualitative
Time
15 minutes
LOD
1800 AU
Calibration
Not evaluated
Analysis of cross reactivity
Evaluated
False positives
0 %
False negatives
2.47 % (2 false negative on 81 samples tested positive by PCR)
Precision
Evaluated
Accuracy
96.9 %
Reproducibility
Evaluated
Robustness
Evaluated
Clinical Sensitivity
97.7 %
The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements